Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 60 Breast Neoplasms 54 Ovarian Neoplasms 35 Triple Negative Breast Neoplasms 28 Lung Neoplasms 25 Fallopian Tube Neoplasms 24 Endometrial Neoplasms 24 Neoplasm Metastasis 22 Squamous Cell Carcinoma of Head and Neck 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 19 Neoplasms 15 Esophageal Neoplasms 13 Esophageal Squamous Cell Carcinoma 12 Carcinoma, Ovarian Epithelial 10 Stomach Neoplasms 9 Head and Neck Neoplasms 9 Carcinoma 9 Colorectal Neoplasms 8 Adenocarcinoma Of Esophagus 7 Adenocarcinoma 7 Peritoneal Neoplasms 6 Uterine Cervical Neoplasms 5 Melanoma 5 Small Cell Lung Carcinoma 4 Oropharyngeal Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Respiratory Tract Neoplasms 3 Recurrence 3

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cystic Neoplasm × Paclitaxel × 90 days × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡